C2N Diagnostics Introduces P-tau Multi-Analyte Assay for Research Use Only to Advance Alzheimer's Disease and Brain Health Field - Business Wire

5/18/2022 12:00:00 AM2 years 11 months ago
C2N Diagnostics, a leader in advanced brain health diagnostics that offers the PrecivityAD™ blood test as an aid to Alzheimer’s disease diagnosis, tod
ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, a leader in advanced brain health diagnostics that offers the PrecivityAD blood test as an aid to Alzheimers disease diagnosis, today announced its latest… [+4711 chars]
full article...